Cantor Fitzgerald analyst Steve Seedhouse reiterated a Neutral rating on Tvardi Therapeutics Inc (NASDAQ: TVRD).The analyst commented, "We remain Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE